Granulocyte colony-stimulating factor improves neuron survival in experimental spinal cord injury by regulating nucleophosmin-1 expression

Journal of Neuroscience Research

Volumn 92, Issue 6, 2014, Pages 751-760

  Guo, Yuji ^a   Liu, Shangming ^a   Wang, Ping ^b   Zhang, Hui ^a   Wang, Fuwu ^a   Bing, Lujun ^a   Gao, Jiangang ^c   Yang, Jie ^d   Hao, Aijun ^a  

^a SHANDONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b THE SECOND HOSPITAL OF SHANDONG UNIVERSITY   (China)

^c SHANDONG UNIVERSITY   (China)

^d SHANDONG UNIVERSITY   (China)

Author keywords

Apoptosis; Granulocyte colony stimulating factor; Nucleophosmin 1; P53; Spinal cord injury

Indexed keywords

GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE COLONY STIMULATING FACTOR RECEPTOR; NUCLEOPHOSMIN; PROTEIN P53; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; NUCLEAR PROTEIN; RECOMBINANT PROTEIN;

ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BLOOD BRAIN BARRIER; CELL ISOLATION; CELL SURVIVAL; CONTROLLED STUDY; FEMALE; IMMUNOFLUORESCENCE; IMMUNOHISTOLOGY; IN VITRO STUDY; LOCOMOTION; MOUSE; NERVE CELL; NERVE CELL CULTURE; NEUROPROTECTION; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPINAL CORD HEMISECTION; SPINAL CORD INJURY; TREATMENT DURATION; WESTERN BLOTTING; ANIMAL; BIOSYNTHESIS; CONVALESCENCE; DISEASE MODEL; DRUG EFFECTS; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION REGULATION; HUMAN; METABOLISM; MOTOR ACTIVITY; PATHOLOGY; PHYSIOLOGY;

ANIMALS; APOPTOSIS; BLOTTING, WESTERN; CELL SURVIVAL; DISEASE MODELS, ANIMAL; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION REGULATION; GRANULOCYTE COLONY-STIMULATING FACTOR; HUMANS; IN SITU NICK-END LABELING; MICE; MOTOR ACTIVITY; NEURONS; NUCLEAR PROTEINS; RECOMBINANT PROTEINS; RECOVERY OF FUNCTION; SPINAL CORD INJURIES;

EID: 84897573175     PISSN: 03604012     EISSN: 10974547     Source Type: Journal    
DOI: 10.1002/jnr.23362     Document Type: Article

References (45)

1. Ahn JY, Liu X, Cheng D, Peng J, Chan PK, Wade PA, Ye K. 2005. Nucleophosmin/B23, a nuclear PI(3, 4, 5)P(3) receptor, mediates the antiapoptotic actions of NGF by inhibiting CAD. Mol Cell 18:435-445.
2. Arvanian VL, Schnell L, Lou L, Golshani R, Hunanyan A, Ghosh A, Pearse DD, Robinson JK, Schwab ME, Fawcett JW, Mendell LM. 2009. Chronic spinal hemisection in rats induces a progressive decline in transmission in uninjured fibers to motoneurons. Exp Neurol 216:471-480.
3. Bartolini A, Vigliani MC, Magrassi L, Vercelli A, Rossi F. 2011. G-CSF administration to adult mice stimulates the proliferation of microglia but does not modify the outcome of ischemic injury. Neurobiol Dis 41:640-649.
4. Basso DM, Beattie MS, Bresnahan JC. 1995. A sensitive and reliable locomotor rating scale for open field testing in rats. J Neurotrauma 12:1-21.
5. Chan HJ, Weng JJ, Yung BY. 2005. Nucleophosmin/B23-binding peptide inhibits tumor growth and upregulates transcriptional activity of p53. Biochem Biophys Res Commun 333:396-403.
6. Chou CC, Yung BY. 2001. Increased stability of nucleophosmin/B23 in anti-apoptotic effect of ras during serum deprivation. Mol Pharmacol 59:38-45.
7. Colombo E, Marine JC, Danovi D, Falini B, Pelicci PG. 2002. Nucleophosmin regulates the stability and transcriptional activity of p53. Nat Cell Biol 4:529-533.
8. Crowe MJ, Bresnahan JC, Shuman SL, Masters JN, Beattie MS. 1997. Apoptosis and delayed degeneration after spinal cord injury in rats and monkeys. Nat Med 3:73-76.
9. Das M, Patil S, Bhargava N, Kang JF, Riedel LM, Seal S, Hickman JJ. 2007. Auto-catalytic ceria nanoparticles offer neuroprotection to adult rat spinal cord neurons. Biomaterials 28:1918-1925.
10. Garg R, Faderl S, Garcia-Manero G, Cortes J, Koller C, Huang X, York S, Pierce S, Brandt M, Beran M, Borthakur G, Kantarjian H, Ravandi F. 2009. Phase II study of rabbit anti-thymocyte globulin, cyclosporine and granulocyte colony-stimulating factor in patients with aplastic anemia and myelodysplastic syndrome. Leukemia 23:1297-1302.
11. Grisendi S, Bernardi R, Rossi M, Cheng K, Khandker L, Manova K, Pandolfi PP. 2005. Role of nucleophosmin in embryonic development and tumorigenesis. Nature 437:147-153.
12. Grisendi S, Mecucci C, Falini B, Pandolfi PP. 2006. Nucleophosmin and cancer. Nat Rev Cancer 6:493-505.
13. Guest JD, Hiester ED, Bunge RP. 2005. Demyelination and Schwann cell responses adjacent to injury epicenter cavities following chronic human spinal cord injury. Exp Neurol 192:384-393.
14. Henriques A, Pitzer C, Dupuis L, Schneider A. 2010. G-CSF protects motoneurons against axotomy-induced apoptotic death in neonatal mice. BMC Neurosci 11:25.
15. Hingorani K, Szebeni A, Olson MO. 2000. Mapping the functional domains of nucleolar protein B23. J Biol Chem 275:24451-24457.
16. Horner PJ, Power AE, Kempermann G, Kuhn HG, Palmer TD, Winkler J, Thal LJ, Gage FH. 2000. Proliferation and differentiation of progenitor cells throughout the intact adult rat spinal cord. J Neurosci 20: 2218.
17. Jung KH, Chu K, Lee ST, Kim SJ, Sinn DI, Kim SU, Kim M, Roh JK. 2006. Granulocyte colony-stimulating factor stimulates neurogenesis via vascular endothelial growth factor with STAT activation. Brain Res 1073-1074:190-201.
18. Kadia TM, Borthakur G, Garcia-Manero G, Faderl S, Jabbour E, Estrov Z, York S, Huang X, Pierce S, Brandt M, Koller C, Kantarjian HM, Ravandi F. 2012. Final results of the phase II study of rabbit anti-thymocyte globulin, ciclosporin, methylprednisone, and granulocyte colony-stimulating factor in patients with aplastic anaemia and myelodysplastic syndrome. Br J Haematol 157:312-320.
19. Lambert B, Buckle M. 2006. Characterisation of the interface between nucleophosmin (NPM) and p53: potential role in p53 stabilisation. FEBS Lett 580:345-350.
20. Li J, Zhang X, Sejas DP, Pang Q. 2005. Negative regulation of p53 by nucleophosmin antagonizes stress-induced apoptosis in human normal and malignant hematopoietic cells. Leukemia Res 29:1415-1423.
21. Li X, Meng H, Chen BD. 2009. Differentiation-associated expression of conventional protein kinase C isoforms in primary cultures of bone marrow cells induced by M-CSF and G-CSF. Am J Biomed Sci 1:47-55.
22. Lindström MS. 2011. NPM1/B23: a multifunctional chaperone in ribosome biogenesis and chromatin remodeling. Biochem Res Int 2011:195209.
23. Liu H, Jia D, Fu J, Zhao S, He G, Ling EA, Gao J, Hao A. 2009. Effects of granulocyte colony-stimulating factor on the proliferation and cell-fate specification of neural stem cells. Neuroscience 164:1521-1530.
24. Ma YH, Zeng X, Zhang K, Zeng YS. 2012. A new in vitro injury model of mouse neurons induced by mechanical scratching. Neurosci Lett 510:14-19.
25. Namboodiri VM, Akey IV, Schmidt-Zachmann MS, Head JF, Akey CW. 2004. The structure and function of Xenopus NO38-core, a histone chaperone in the nucleolus. Structure 12:2149-2160.
26. Nishio Y, Koda M, Kamada T, Someya Y, Kadota R, Mannoji C, Miyashita T, Okada S, Okawa A, Moriya H, Yamazaki M. 2007. Granulocyte colony-stimulating factor attenuates neuronal death and promotes functional recovery after spinal cord injury in mice. J Neuropathol Exp Neurol 66:724-731.
27. Osada T, Watanabe M, Hasuo A, Imai M, Suyama K, Sakai D, Kawada H, Matsumae M, Mochida J. 2010. Efficacy of the coadministration of granulocyte colony-stimulating factor and stem cell factor in the activation of intrinsic cells after spinal cord injury in mice. J Neurosurg Spine 13:516-523.
28. Pan HC, Cheng FC, Lai SZ, Yang DY, Wang YC, Lee MS. 2008. Enhanced regeneration in spinal cord injury by concomitant treatment with granulocyte colony-stimulating factor and neuronal stem cells. J Clin Neurosci 15:656-664.
29. Pitzer C, Krüger C, Plaas C, Kirsch F, Dittgen T, Müller R, Laage R, Kastner S, Suess S, Spoelgen R, Henriques A, Ehrenreich H, Schäbitz WR, Bach A, Schneider A. 2008. Granulocyte-colony stimulating factor improves outcome in a mouse model of amyotrophic lateral sclerosis. Brain 131:3335-3347.
30. Profyris C, Cheema SS, Zang D, Azari MF, Boyle K, Petratos S. 2004. Degenerative and regenerative mechanisms governing spinal cord injury. Neurobiol Dis 15:415-436.
31. Qi W, Shakalya K, Stejskal A, Goldman A, Beeck S, Cooke L, Mahadevan D. 2008. NSC348884, a nucleophosmin inhibitor disrupts oligomer formation and induces apoptosis in human cancer cells. Oncogene 27:4210-4220.
32. Qing Y, Yingmao G, Lujun B, Shaoling L. 2008. Role of Npm1 in proliferation, apoptosis and differentiation of neural stem cells. J Neurol Sci 266:131-137.
33. Savkur RS, Olson MO. 1998. Preferential cleavage in pre-ribosomal RNA byprotein B23 endoribonuclease. Nucleic Acids Res 26:4508-4515.
34. Schneider A, Krüger C, Steigleder T, Weber D, Pitzer C, Laage R, Aronowski J, Maurer MH, Gassler N, Mier W, Hasselblatt M, Kollmar R, Schwab S, Sommer C, Bach A, Kuhn HG, Schäbitz WR. 2005. The hematopoietic factor G-CSF is a neuronal ligand that counteracts programmed cell death and drives neurogenesis. J Clin Invest 115:2083-2098.
35. Sheibani N, Grabowski EF, Schoenfeld DA, Whalen MJ. 2004. Effect of granulocyte colony-stimulating factor on functional and histopathologic outcome after traumatic brain injury in mice. Crit Care Med 32:2274-2279.
36. Shyu WC, Lin SZ, Yang HI, Tzeng YS, Pang CY, Yen PS, Li H. 2004. Functional recovery of stroke rats induced by granulocyte colony-stimulating factor-stimulated stem cells. Circulation 110:1847-1854.
37. Silvestris N, Del Re M, Azzariti A, Maiello E, Lombardi L, Cinieri S, Guarini A, Brunetti AE, Delcuratolo S, De Vita F, Pisconti S, Danesi R, Colucci G. 2012. Optimized granulocyte colony-stimulating factor prophylaxis in adult cancer patients: from biological principles to clinical guidelines. Expert Opin Ther Targets 16(Suppl 2):S111-S117.
38. Swaminathan V, Kishore AH, Febitha KK, Kundu TK. 2005. Human histone chaperone nucleophosmin enhances acetylation-dependent chromatin transcription. Mol Cell Biol 25:7534-7545.
39. van de Geijn GJ, Aarts LH, Erkeland SJ, Prasher JM, Touw IP. 2003. Granulocyte colony-stimulating factor and its receptor in normal hematopoietic cell development and myeloid disease. Rev Physiol Biochem Pharmacol 149:53-71.
40. Welte K, Platzer E, Lu L, Gabrilove JL, Levi E, Mertelsmann R, Moore MA. 1985. Purification and biochemical characterization of human pluripotent hematopoietic colony-stimulating factor. Proc Natl Acad Sci U S A 82:1526-1530.
41. Wilhelmsson U, Bushong EA, Price DL, Smarr BL, Phung V, Terada M, Ellisman MH, Pekny M. 2006. Redefining the concept of reactive astrocytes as cells that remain within their unique domains upon reaction to injury. Proc Natl Acad Sci U S A 103:17513-17518.
42. Wu MH, Yung BY. 2002. UV stimulation of nucleophosmin/B23 expression is an immediate-early gene response induced by damaged DNA. J Biol Chem 277:48234-48240.
43. Yamasaki R, Tanaka M, Fukunaga M, Tateishi T, Kikuchi H, Motomura K, Matsushita T, Ohyagi Y, Kira J. 2010. Restoration of microglial function by granulocyte-colony stimulating factor in ALS model mice. J Neuroimmunol 229:51-62.
44. You BJ, Huang IJ, Liu WH, Hung YB, Chang JH, Yung BY. 1999. Decrease in nucleophosmin/B23 mRNA and telomerase activity during indomethacin-induced apoptosis of gastric KATO-III cancer cells. Naunyn Schmiedebergs Arch Pharmacol 60:683-690.
45. Zhao LR, Navalitloha Y, Singhal S, Mehta J, Piao CS, Guo WP, Kessler JA, Groothuis DR. 2007. Hematopoietic growth factors pass through the blood-brain barrier in intact rats. Exp Neurol 204:569-573.